Regulation of MAP kinase activity by peptide receptor signalling pathway: Paradigms of multiplicity

被引:249
作者
Liebmann, C [1 ]
机构
[1] Univ Jena, Fac Biol & Pharmaceut, Inst Biochem & Biophys, D-07743 Jena, Germany
关键词
peptide receptors; mitogenic/antimitogenic signalling; MAPK; RTK; PKC; PI-3K;
D O I
10.1016/S0898-6568(01)00192-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
G protein-coupled receptors (GPCRs) can stimulate the mitogen-activated protein kinase (MAPK) cascade and thereby induce cellular proliferation like receptor tyrosine kinases (RTKs). Work over the past 5 years has established several models which reduce the links of G(i)-, G(q)-, and G(s)-coupled receptors to MAPK on few principle pathways. They include (i) Ras-dependent activation of MAPK via transactivation of RTKs such as the epidermal growth factor receptor (EGFR), (h) Ras-independent MAPK activation via protein kinase C (PKC) that converges with the RTK signalling at the level of Raf, and (iii) activation as well as inactivation of MAPK via the cAMP/protein kinase A (PKA) pathway in dependency on the type of Raf Most of these generalizing hypotheses are founded on experimental data obtained from expression studies and using a limited set of individual receptors. This review will compare these models with pathways to MAPK found for a great variety of peptide hormone and neuropeptide receptor subtypes in various cells. It becomes evident that under endogenous conditions, the transactivation pathway is less dominant as postulated, whereas pathways involving isoforms of PKC and, especially, phosphoinositide 3-kinase (PI-3K) appear to play a more important role as assumed so far. Highly cell-specific and unusual connections of signalling proteins towards MAPK, in particular tumour cells, might provide points of attacks for new therapeutic concepts. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:777 / 785
页数:9
相关论文
共 109 条
[1]  
Adomeit A, 1999, MOL CELL BIOL, V19, P5289
[2]   Stimulation of 42/44 kDa mitogen-activated protein kinases by arginine vasopressin in rat cardiomyocytes [J].
Aharonovitz, O ;
Aboulafia-Etzion, S ;
Leor, J ;
Battler, A ;
Granot, Y .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1401 (01) :105-111
[3]   MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway [J].
Ai, WD ;
Gong, JH ;
Yu, L .
FEBS LETTERS, 1999, 456 (01) :196-200
[4]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[5]   Effect of bradykinin on tyrosine kinase and phosphatase activities and cell proliferation in mesangial cells [J].
Alric, C ;
Pecher, C ;
Bascands, JL ;
Girolami, JP .
IMMUNOPHARMACOLOGY, 1999, 45 (1-3) :57-62
[6]   Adrenomedullin enhances cell proliferation and deoxyribonucleic acid synthesis in rat adrenal zona glomerulosa: Receptor subtype involved and signaling mechanism [J].
Andreis, PG ;
Markowska, A ;
Champion, HC ;
Mazzocchi, G ;
Malendowicz, LK ;
Nussdorfer, GG .
ENDOCRINOLOGY, 2000, 141 (06) :2098-2104
[7]   Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a ras-independent, mitogen-activated protein kinase ERK kinase 1 or 2-dependent manner in PC12 cells [J].
Barrie, AP ;
Clohessy, AM ;
Buensuceso, CS ;
Rogers, MV ;
Allen, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (32) :19666-19671
[8]  
Belcheva MM, 1998, J NEUROCHEM, V70, P635
[9]   Emergent properties of networks of biological signaling pathways [J].
Bhalla, US ;
Iyengar, R .
SCIENCE, 1999, 283 (5400) :381-387
[10]   Activation of mitogen-activated protein kinase by the bradykinin B2 receptor is independent of receptor phosphorylation and phosphorylation-triggered internalization [J].
Blaukat, A ;
Pizard, A ;
Rajerison, RM ;
Alhenc-Gelas, F ;
Müller-Esterl, W ;
Dikic, I .
FEBS LETTERS, 1999, 451 (03) :337-341